Multi-layered spatial transcriptomics identify secretory factors promoting human hematopoietic stem cell development by Crosse, Edie et al.
 
 
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Multi-layered spatial transcriptomics identify secretory factors
promoting hematopoietic stem cell emergence in human
development
Citation for published version:
Crosse, E, Gordon-Keylock, S, Rybtsov, S, Binagui-Casas, A, Felchle, H, Nnadi, N, Kirschner, K, Chandra,
T, Tamagno, S, Webb, DJ, Rossi, F, Anderson, RA & Medvinsky, A 2020, 'Multi-layered spatial
transcriptomics identify secretory factors promoting hematopoietic stem cell emergence in human
development', Cell Stem Cell, vol. 27, no. 5, pp. 822-839.e8. https://doi.org/10.1016/j.stem.2020.08.004
Digital Object Identifier (DOI):
10.1016/j.stem.2020.08.004
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Cell Stem Cell
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 03. Dec. 2020
ResourceMulti-layered Spatial Transcriptomics Identify
Secretory Factors Promoting Human Hematopoietic
Stem Cell DevelopmentGraphical AbstractHighlightsd Spatial transcriptome profiling of the human HSC
developmental niche
d Characterization of an HSC precursor population at single-
cell resolution
d Cardiac EGF pathway is ventrally enriched next to developing
IAHCs/HSCs
d Ventrally secreted endothelin promotes development
of HSCsCrosse et al., 2020, Cell Stem Cell 27, 822–839
November 5, 2020 ª 2020 Elsevier Inc.
https://doi.org/10.1016/j.stem.2020.08.004Authors
Edie I. Crosse,
Sabrina Gordon-Keylock,
Stanislav Rybtsov, ..., Fiona Rossi,
Richard A. Anderson,
Alexander Medvinsky
Correspondence
a.medvinsky@ed.ac.uk
In Brief
Crosse et al. combined spatial,
population, and single-cell
transcriptomics to interrogate signaling in
the human hematopoietic stem cell (HSC)
embryonic niche. They identified
secreted proteins proximal to the site of
HSC emergence, including endothelins,
which, they demonstrated, can promote
hematopoiesis in mouse and human.ll
llResource
Multi-layered Spatial Transcriptomics Identify
Secretory Factors Promoting Human
Hematopoietic Stem Cell Development
Edie I. Crosse,1 Sabrina Gordon-Keylock,1 Stanislav Rybtsov,1 Anahi Binagui-Casas,1 Hannah Felchle,1 Nneka C. Nnadi,1
Kristina Kirschner,2 Tamir Chandra,3 Sara Tamagno,1 David J. Webb,4 Fiona Rossi,1 Richard A. Anderson,5
and Alexander Medvinsky1,6,*
1MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK
2Institute of Cancer Sciences, University of Glasgow, Bearsden G61 1QH, UK
3MRC Human Genetics Unit, University of Edinburgh, Edinburgh EH4 2XU, UK
4BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK
5MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh EH16 4TJ UK
6Lead Contact
*Correspondence: a.medvinsky@ed.ac.uk
https://doi.org/10.1016/j.stem.2020.08.004SUMMARYHematopoietic stem cells (HSCs) first emerge in the embryonic aorta-gonad-mesonephros (AGM) region.
Studies of model organisms defined intersecting signaling pathways that converge to promote HSC emer-
gence predominantly in the ventral domain of the dorsal aorta. Much less is known about mechanisms driving
HSC development in humans. Here, to identify secreted signals underlying humanHSC development, we com-
bined spatial transcriptomics analysis of dorsoventral polarized signaling in the aorta with gene expression
profiling of sorted cell populations and single cells. Our analysis revealed a subset of aortic endothelial cells
with a downregulated arterial signature and a predicted lineage relationship with the emerging HSC/progenitor
population. Analysis of the ventrally polarized molecular landscape identified endothelin 1 as an important
secreted regulator of human HSC development. The obtained gene expression datasets will inform future
studies on mechanisms of HSC development in vivo and on generation of clinically relevant HSCs in vitro.INTRODUCTION
The first definitive hematopoietic stem cells (HSCs) that give rise
to the adult hematopoietic system in mouse and human emerge
in the embryonic aorta-gonad-mesonephros (AGM) region
(Medvinsky and Dzierzak, 1996; Ivanovs et al., 2011; de Bruijn
et al., 2000). Generation of HSCs and progenitor cells is mani-
fested as formation of intra-aortic hematopoietic cell clusters
(IAHCs), conserved across vertebrates (Garcia-Porrero et al.,
1995; Medvinsky et al., 1996; Tavian et al., 1996; Tavian et al.,
1999; Jaffredo et al., 1998; Ciau-Uitz et al., 2000; Yokomizo
and Dzierzak, 2010). IAHCs/HSCs are formed through transition
of the aortic endothelium toward the hematopoietic fate in a pro-
cess termed endothelial-to-hematopoietic transition (EHT) (Jaf-
fredo et al., 1998; Zovein et al., 2008;Medvinsky et al., 2011; Bat-
sivari et al., 2017; Chen et al., 2009; Taoudi et al., 2008; Kissa and
Herbomel, 2010; Bertrand et al., 2010). In themouse, HSCmatu-
ration is accompanied by sequential upregulation of the hemato-
poietic markers CD41, CD43, and CD45 and critical transcription
factors (TFs) such as Runx1, Gata2, and Gfi1 (Mikkola et al.,
2003; Taoudi et al., 2005; Nottingham et al., 2007; Boisset
et al., 2010; Rybtsov et al., 2011; de Pater et al., 2013; Rybtsov
et al., 2014; Thambyrajah et al., 2016; Baron et al., 2018).822 Cell Stem Cell 27, 822–839, November 5, 2020 ª 2020 Elsevier IIn the human embryo, definitive HSCs emerge between Car-
negie stage 14 (CS14) andCS17 (postovulatory days 32–41) (Iva-
novs et al., 2011), which overlaps with the time of appearance of
IAHCs (Tavian et al., 1996, 1999). To date, human EHT cannot be
tracked directly in vivo. However, in vitro modeling using human
embryonic stem cells (hESCs) revealed transition through endo-
thelial intermediates toward the hematopoietic fate (Slukvin,
2013; Ayllón et al., 2015; Ditadi et al., 2015; Rönn et al., 2015; Di-
tadi et al., 2017). Recent single-cell transcriptomics analysis at
earlier CS12–CS14 (postovulatory days 27–32) also indicated a
lineage relationship between human endothelium and hemato-
poietic stem and progenitor cells (HSPCs) (Zeng et al., 2019).
IAHCs/HSCs emerge predominantly in the ventral domain of
the dorsal aorta (AoV), which has been identified as the func-
tional HSC niche in mouse and human (Peeters et al., 2009;
Taoudi and Medvinsky, 2007; Ivanovs et al., 2014; Souilhol
et al., 2016a; McGarvey et al., 2017; Ciau-Uitz et al., 2016). Sub-
sequent analysis of ventrally polarized secreted factors revealed
their important role in mouse HSC development (Souilhol et al.,
2016a; McGarvey et al., 2017). Although analysis of vertebrate
models shed light on early hematopoietic development, the
mechanisms underpinning this process in human are much
less clear (Easterbrook et al., 2019).nc.
(legend on next page)
ll
Resource
Cell Stem Cell 27, 822–839, November 5, 2020 823
ll
ResourceHere we aimed to spatially characterize the developing HSC
niche (hereafter referred to as ‘‘niche’’) and identify secreted fac-
tors involved in early human HSC development. Using laser cap-
ture microdissection coupled with RNA sequencing (LCM-seq),
we investigated dorsal-ventral (D-V) molecular differences
across the dorsal aorta (Ao) with a focus on cell layers close to
IAHC formation. We also studied gene expression dynamics
across EHT within the aortic niche at the population and sin-
gle-cell levels and revealed a close link of emerging HSPCs
with a specific endothelial cell subset in which the arterial signa-
ture was markedly downregulated.
Our analyses identified numerous ventrally polarized signaling
pathways, including those with a well-documented role in HSPC
development. We focused on one of them, cardiac epidermal
growth factor (EGF), not implicated previously in HSC develop-
ment and found that its major regulator, endothelin 1, enhances
the multipotency of human ES cell-derived hematopoietic pro-
genitors, whereas in the mouse, the highly similar isoform endo-
thelin 2 is a strong pro-HSC maturation factor. Additionally, the
gene expression database generated here can provide deep in-
sights into normal and potentially congenital pathological pro-
cesses related to blood development and potentially inform stra-
tegies to gain better control of ex vivo HSC manipulations.
RESULTS
Mapping D-V Signaling Polarization in the HSC
Developmental Niche
To reveal D-V polarization within the human Ao, we performed
spatially defined microdissection using LCM. Transverse cryo-
sections of CS16–CS17 embryos were taken between the liver
caudal border (rostral limit) and the midgut loop (caudal limit)
(Figures 1A and S1A), where IAHCs/HSCs predominantly
emerge (Tavian et al., 1996; Tavian et al., 1999; Easterbrook
et al., 2019).
Two types of microdissections were performed. In the first se-
ries (LCM-seq1), the Ao walls (3–4 cell layers thick, CS17 em-
bryos, n= 3), were dissected into ventral ([V]), ventrolateral
([VL]), dorsolateral ([DL]) and dorsal ([D]) subdomains (Figure 1B;
Table S1). In the second series (LCM-seq2), three concentric cell
layers were microdissected, radiating away from the Ao lumen
(CS16 embryos, n = 3), referred to as inner (luminal endothelial
and perivascular cells), mid (subendothelial stromal cells), and
outer (more distal stromal cells) (Figure 1B). Each layer was sub-
dissected along the midline into dorsal and ventral domains (see
nomenclature in Table S1) and used for RNA sequencing (RNA-
seq). In both experiments, sister sections were immunostainedFigure 1. Signaling Heterogeneity along the D-V Axis of the Ao
(A) Schematic of a CS16–CS17 embryo. The region highlighted in yellow is taken
Figure S1. Ao, dorsal aorta; Duo, duodenum; SMA, superior mesenteric artery; M
(B) Strategy of LCM-mediated subdissection (left) superimposed onto an examp
ventral; VL, ventrolateral; DL, dorsal-lateral; D, dorsal; 1, V_Inner; 2, D_Inner; 3, V
(C) Sister section stained for CDH5 and Runx1 using antibody staining. The arro
(B and C) The D-V axis is indicated.
(D and E) Top pathways by false discovery rate (FDR) for LCM-seq domains highli
indicated in the schematic above. FDR < 0.25.
(D) LCM-seq1: D, DL, VL, and V (each versus the remaining 3 domains).
(E) LCM-seq2: V_Inner (red) versus D_Inner (green) (E’) and V_Mid (yellow) versu
Numbers of significant differentially expressed genes for each contrast are show
824 Cell Stem Cell 27, 822–839, November 5, 2020for CDH5 (VE-Cadherin) and Runx1 to validate the presence of
CDH5+Runx1+ IAHCs (Figure 1C). Thus, D-V polarization was
assessed at two levels: across the entire Ao diameter (LCM-
seq1) and across the entire Ao wall depth (LCM-seq2), enabling
prioritization of key genes.
Molecular Signaling Is Polarized along the D-V Axis
Gene set enrichment analysis (GSEA) of the LCM-seq1 dataset
revealed an exceptionally high pathway number enriched in
[VL] (250) compared with [V] (4), [DL] (4), and [D] (5) (Data S1).
[VL] was enriched for neuro-specific pathways (e.g., long-term
potentiation, unblocking of NMDA receptors, glutamate binding
and activation, neurexins and neuroglins, and neuroactive ligand
receptor interaction; (Figure 1D), in keeping with the proximity to
ventrolaterally localized sympathetic ganglia, an important
component of the HSC niche (Fitch et al., 2012). Notably, [V]
showed enrichment of transforming growth factor b (TGF-b)
signaling, observed previously in the mouse AoV (McGarvey
et al., 2017).
The second dataset, LCM-seq2, revealed D-V differences
across the Ao wall and deeper stromal layers (Figures 1E and
S2C). As expected, endothelial (PECAM1, CDH5, and CD34)
and perivascular markers (ACTA2, ACTC1, and CSPG4 [NG2])
were highly expressed in the inner layer, followed by a decrease
in endothelial (but sustained perivascular markers) in the mid
layer and a further decrease of these markers in the outer layer
(Figure S1C). Principal-component analysis (PCA) clustered
samples by biological variant along principal component 1
(PC1) and PC2, highlighting biological variability between human
samples (biological variability is less marked for LCM-seq1) (Fig-
ures S1D and S1E). By PC3, stratification (and distinct molecular
identities) of the inner, mid, and outer layers became evident
(Figure S1E’’). For subsequent differential expression analysis,
biological variability was corrected (STAR Methods).
GSEA identified inner layer-specific pathways involved in
blood vessel function, maintenance, and angiogenesis (including
smooth muscle contraction, integrin b3, and TGF-b signaling)
(Figures S2A and S2B). Notably, ventrally enriched pathways in
all three concentric layers included tumor necrosis factor alpha
(TNF-a) signaling via nuclear factor kB, phosphatidylinositol 3-ki-
nase (PI3K) AKTMTOR signaling, andmetabolism of nitric oxide,
associated with HSC development (Figures 1E and S2C; Data
S1) (Adamo et al., 2009; North et al., 2009; Wang et al., 2011; Es-
pı́n-Palazón et al., 2014; Zhou et al., 2016). Additionally, the
V_Outer compared with the D_Outer layer was enriched for
some known hematopoietic factors, including EPO and TPO
(Figure S2C). Thus, all AoV cell layers can potentially contribute
to ventrally polarized development of the adult hematopoieticfor LCM-seq; anatomical landmarks of rostral and caudal limits are shown in
G, midgut loop; UC, umbilical cord.
le Ao transverse section (right) for LCM-seq1 (top) and LCM-seq2 (bottom). V,
_Mid; 4, D_Mid; 5, V_Outer; 6, D_Outer; Mn, mesonephros; nc, notochord.
whead indicates an IAHC adhering to the V endothelium.
ghted in the schematic. The color of the table corresponds with the subdomain
s D_Mid (blue) (E’’).
n in Figure S1B.
Figure 2. Spatial Molecular Polarization across the Ao Wall and Surrounding Stroma (LCM-Seq2)
(A and B) Enrichment plots for V_Inner versus D_Inner ‘‘Cardiac EGF’’ pathway (A) and V_Mid versus D_Mid TNF-a signaling via NF-kB (B). Contributing genes are
shown. Endothelin- and angiotensin-related genes are highlighted in red.
(C) LCM-seq2: the expression levels of EDN1 decrease with distance from the Ao lumen (LCM-seq2) (adjusted p value [p.adj] = 2 3 107; N = 3, indicated by
different colors).
(D) LCM-seq1: the expression levels of REN increase significantly from D and DL to V and VL.
(E) Volcano plot of significant genes, V_Mid versus D_Mid, with secreted factors marked (positive loading versus negative loading, respectively). REN (most
significant secreted factor (p.adj = 1.8 3 106) and EDN1 are marked by blue boxes.
ll
Resourcesystem. Furthermore, despite polarization across the AoV depth,
a remarkable integrity between the V_Inner and V_Mid concen-
tric layers (283 pathways shared) (Figure S2D), suggested strong
functional coherence within the developing HSC niche. The
same AoD concentric layers shared only 37 pathways, indicating
functional heterogeneity.
Renin and Endothelin 1 Are Ventrally Enriched Secreted
Factors
AoV secreted factors are potential key HSC niche signaling mol-
ecules. Intriguingly, V_Inner, intimately related to IAHC forma-
tion, was enriched for the cardiac EGF pathway currently not
associated with HSC development (Figures 1E’ and 2A). This
pathway is stimulated by the secreted factor endothelin 1
(EDN1) and the renin-angiotensin pathway ligand angiotensin II
(causing cardiac hypertrophy in response to high blood pres-
sure) (Shah and Catt, 2003). Indeed, EDN1, EDNRB (endothelin
receptor B), and AGTR2 (angiotensin receptor 2) contributed to
V_Inner (versus D_Inner) and V_Mid (versus D_Mid) enrichment(Figure 2A). EDN1 also contributed to ventral enrichment of
HSC-related TNF-a signaling via NF-kB in V_Inner and V_Mid
(Figure 2B). EDN1 was the most significant secreted factor that
showed a monotonic expression gradient, increasing toward
the Ao lumen (Figure 2C). Notably, among three genes (LCM-
seq1) with monotonic expression growing from [D]/[DL] toward
[V]/[VL] wasREN (Figure 2D), which acts upstreamof angiotensin
II and angiotensin-converting enzyme (ACE), a suggested HSC
marker in the human AGM (Jokubaitis et al., 2008; Sinka et al.,
2012). Additionally, REN was the most significantly upregulated
secreted factor in V_Mid versus D_Mid (Figures 2E and S2E). The
entire renin-angiotensin pathway was also enriched in V_Outer
versus D_Outer (Figure S2C). Renin and endothelin 1, both en-
coding blood pressure regulators, have a reciprocal and interac-
tive relationship (Beierwaltes and Carretero, 1992; Lin et al.,
1993; Ackermann et al., 1995; Rossi et al., 1999). Their coinci-
dent ventral enrichment is suggestive of a potential role in the he-
matopoietic niche.Cell Stem Cell 27, 822–839, November 5, 2020 825
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ResourceGene Expression Dynamics across the EHT
Profiling of Three Major EHT Populations
To map gene expression during EHT, the Ao from two embryos
(CS15–CS16) weremanually bisected, and three cell populations
from the AoV and dorsal (AoD) domains were sorted and profiled
by RNA-seq: endothelial CDH5+CD45 cells (V_Endo and
D_Endo), hematopoietic stem/progenitor CDH5+CD45+ cells
(V_HSPCs and D_HSPC), and mature hematopoietic
CDH5CD45+ cells (V_Hem and D_Hem) (Figure S3A; Table
S2). PCA showed clustering according to cell population identity,
except for scattered D_HSPCs (Figure S3B’), whichmight reflect
an unstable nature of hematopoiesis in the AoD (these samples
were excluded from further analysis). As expected, V_HSPC, in
accordance with its intermediate position along the EHT axis,
falls between the V/D_Hem and V/D_Endo populations along
PC1 (Figure S3B’’).
D-V endothelial polarization (Figure S3C) was evident from dif-
ferential gene expression in the V_Endo (36) and D_Endo (58)
populations (Data S2). GSEA again showed TNF-a signaling via
NF-kB and MTORC signaling enrichment in the V_Endo versus
D_Endo population as in all ventral layers detected by LCM-
seq1 (Figures S3D, 1E, and S2C; Data S1). Top significant genes
in V_Endo wereGATA4, STAB2, FGF23, and TBX5 (not detected
by LCM-seq, likely because of confounding signals from non-
endothelial, perivascular cell types) (Figure S3C). Thus, analysis
of purified cell populations complemented spatial LCM-seq and
revealed additional D-V molecular polarization. Notably, EDN1
was also enriched in the sorted V_Endo compared with D_Endo.
Molecular Signaling across EHT
We then profiled differentially expressed TFs, secreted factors,
and cell surface proteins within V_Endo, V_HSPC, and more
mature V_Hem populations (Figures 3A–3C; Data S2) and
observed 5 main patterns. (1) 244 genes upregulated from
V_Endo to V_HSPC and then downregulated in V_Hem popula-
tions provided an ‘‘HSPC signature’’ (Data S2), including the
known TFs GFI1 and MYB (Thambyrajah et al., 2016; Mucenski
et al., 1991; Labastie et al., 1998) but also the less investigated
HLF and SETBP1 (Goyama et al., 2008; Yokomizo et al., 2019;
Figure 3A) and the TEK ligandANGPT1. (2) Other genes were up-
regulated from V_Endo to V_HSPC and stayed upregulated in
V_Hem (e.g., the essential hematopoietic TFs RUNX1 and
SPI1). (3) Here genes were expressed in V_Endo and V_HSPC
but downregulated in the V_Hem population (e.g., the TFs
HOXA9, HEY2, GATA2, and SOX18). (4) Some genes were
downregulated in the V_HSPC population compared with
V_Endo and V_Hem (e.g., the TF MAF, the zinc finger
ZFP36L1, and the secreted factors A2M, VCAN, and IGFBP5),
suggesting that their inhibition may be required for HSPC pro-
duction by the endothelium (Figures 3A and 3B). (5) Finally,
some genes were upregulated in the V_Hem populationFigure 3. Dynamics in Gene Expression across the Endothelial-to-Hem
(A–C) Heatmaps of relative expression levels for TFs (A), secreted factors (B), and
V_HSPC versus V_Hem (p.adj < 0.05).
(D) Patterns of signaling along EHT. Shown is GSEA pathway enrichment for V
Overlapping pathways enriched in V_HSPC in both comparisons are shown in re
(E) StringDB interactions between LCM-seq1 V_Inner (versus D_Inner) and V_Mid (
The size of a node indicates the number of connecting edges. The width of a line
(F) Dot plots of normalized expression levels of endothelin and renin core pathwcompared with V_HSPC and V_Endo (e.g., the TFs GAS7 and
AFF3 and the secreted factor SPP1) (Figure 3C; Data S2).
Further GSEA allowed us to assign ventralized pathways de-
tected by LCM-seq (TGF-b signaling, TNF-a signaling via NF-
kB, and MTORC1) to specific EHT populations. TGF-b signaling
was assigned to V_Endo, MTORC1 to V_HSPC populations, and
TNF-a signaling via NF-kB to V_HSPC and V_Hem populations
(Figure 3D). Notch signaling, enriched in the V_Endo and
V_Hem populations, was downregulated in the V_HSPCs popu-
lation, in line with reports that Notch signaling inhibition is
required for EHT (Tang et al., 2013; Lizama et al., 2015; Souilhol
et al., 2016b; Gama-Norton et al., 2015). In contrast, Myc targets
were upregulated in V_HSPC versus V_Endo and V_Hem, in line
with c-Myc involvement in hematopoietic development and adult
HSC function (Wilson et al., 2004; Dubois et al., 2008).
Modeling the Niche Interactome
We then mapped predicted molecular interactions between
secreted niche factors (V_Inner/Mid, LCM-seq2) and highly ex-
pressed genes in the V_Endo population using StringDB (Fig-
ure 3E). EDN1 showed interactions with SPP1 (osteopontin)
and the V_Endo TF GATA4. Of note, SPP1 and GATA4 have
well-documented roles in cardiac remodeling and hypertrophy,
in line with ventral enrichment of the cardiac EGF pathway (Fig-
ures 1E’ and 2A; Hautala et al., 2001; Mohamed et al., 2015; Oka
et al., 2006). SPP1 also showed a large number of interactions
with V_Endo genes (SOST, FGF23, ITGB3, POU5F1, and
PPARG) and other niche factors, including REN (8 total interac-
tions, confidence > 0.4) (Figure 3E). To infer receptor-ligand in-
teractions between ventral LCM-seq2 and the sorted popula-
tions, we used CellPhoneDB (Efremova et al., 2020; Figures
S4A and S4B). Notable putative receptor-ligand interactions
(p < 0.01) included ANGPT2 (V_Inner/Mid) with the receptor
TEK (TIE2) (V_Endo population) and FGF1, FGF3, FGF4,
FGF17, and FGF19 (V_Inner/Mid) with the receptor FGFR4
(V_HSPC population). As expected, V_Inner has more significant
Notch receptor-ligand interactions with V_Endo than V_HSPC
(V_Inner NOTCH3/4, V_Endo JAG2/DLL4; V_Inner JAG1,
V_Endo NOTCH4), which corresponds to downregulation of
Notch signaling as EHT progresses (Gama-Norton et al., 2015;
Souilhol et al., 2016b) (for a full matrix of receptor-ligand interac-
tions, see Data S2).
Endothelin/Renin Interactive Signaling
The sorted hematoendothelial populations showed no or low
REN expression, consistent with its high expression in V_Mid
but not V_Inner (Figure 3F). AGTR1/2 angiotensin receptor
expression was low, whereas the ATP6AP2 prorenin receptor
was substantially expressed in all hematoendothelial popula-
tions, suggesting renin action via ATP6AP2 independent of
ACE. EDN1 was most highly expressed in endothelial popula-
tions (especially in V_Endo, as stated previously), downregulatedatopoietic Transition (EHT)
receptors (C) that are differentially expressed in V_Endo versus V_HSPC and in
_Endo versus V_HSPC populations and V_HSPC versus V_Hem populations.
d text (FDR < 0.25).
versus D_Mid) secreted factors (red) and V_Endo (versus D_Endo) genes (blue).
indicates confidence of the interaction; confidence levels = 0.4–0.9).
ay genes for hematoendothelial populations.
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Resourceto a minimum in the V_HSPC population, and moderately upre-
gulated in hematopoietic (V+D_Hem) populations. The endothe-
lin-activating enzyme ECE1 was considerably expressed in all
populations, peaking on endothelium (V+D_Endo), and the en-
dothelin receptors EDNRA and EDNRB in all hematoendothelial
populations with low but clear expression in V_HSPC, suggest-
ing a direct effect of endothelin on EHT.Single-Cell RNA-Seq Analysis Reveals Direct Ancestors
of HSPCs
Exploring Hematoendothelial Heterogeneity
To gain further insight, we explored the hematoendothelial het-
erogeneity in AoV (CS16) (Figure 4A). CD34+ cells frommanually
subdissected AoV were purified using beads and transcription-
ally profiled using 10X Genomics. Contaminating CD34 cells
(21%) allowed additional resolution of non-hematoendothelial
niche components. 2,379 cells were clustered using a nonlinear
dimensionality reduction technique, uniform manifold approxi-
mation and projection (UMAP), followed by the Leiden algorithm
to produce 20 clusters (CLs) (Figure 4B).
Visualizing gene markers (Figure 4C) enabled assigning basic
cell-type identities to the CLs (Figure 4B). CL12 represents a pop-
ulation branching into 3 distinct mesenchymal subtypes: perivas-
cular ACTA2+PDGFRB+ CL14 and two unidentified ones,
CYP26A1+ CL13 and SPRR2F+ CL15 (Figures 4B, 4C, and
S5A). Standing alone, CL16 likely represents a population of sym-
pathoadrenal progenitors co-expressing THwith several neuronal
markers; e.g., STMN2,ASCL1, andCADM1 (Figure S5A; DataS3).
There are also 3 separate epithelium-like EPCAM+ CLs: EMX2+
CL17, likely related to the mesonephric epithelium (Pellegrini
et al., 1997); PERPhi CL18 of unclear identity; and CL19, exclu-
sively expressing PTH (parathyroid hormone), an HSC regulator
in adult bone marrow (Calvi et al., 2003; Figures 4B and S5A).
The small CL20 represents POU5F1+ NANOS3+ primordial
germ cells (PGCs) (Figures 4B and S5A).
CD34 and CDH5 mapped 10 CLs (CL1–CL10) containing
endothelial cells or HSPCs (Figures 4B and 4C). A partition-
based graph abstraction (PAGA) topology tree shows a central
group of interconnected endothelial CLs, CL2–CL6 (Figure 4D),
referred to as the central endothelial network. These CLs ex-
press the venous markers APLNR and NR2F2 (COUP-TFII), as
do the branching endothelial CLs CL7–CL9 (Figure 4C). The large
CL1 linked weakly to the central endothelial network, expresses
predominantly arterial markers (GJA5 and HEY2), and is referred
to as arterial endothelium (Figures 4C and 4D). However, some
markers considered to be arterial, including SOX7, SOX17,
NOTCH1, and NRP1, are expressed across the central endothe-Figure 4. Exploring Heterogeneity of the Hematoendothelial Populatio
(A) Experimental strategy for single-cell analysis. A CS16 Ao was bisected into V
suspension and subjected to 10X single-cell sequencing.
(B) UMAP with Leiden clustering of the CS16 AoV single-cell dataset (N = 1, n = 2
sympathoadrenal nervous system). The central endothelial network (CL1–CL7) lin
into mature blood cells (CL11). Note that the arterial CL1 linked to HSPC CL10 v
directed graph visualization; D). For a detailed description of all CLs, see Results
(C) Mapped ln-normalized expression of key genes identifying cell subtypes.
(D) Force-directed graph visualization and partition-based graph abstraction (PAG
ismost strongly linked to the bridgingCL5with a downregulated arterial signature
of edges in PAGA indicate the strength of connectivity between CLs.
(E) Mean expression for top 3 markers in each CL revealed in (B) (the plot is ln nlial network and CL1, suggesting ambiguity in distinction be-
tween arterial and venous endothelium (Figure S5B; Corada
et al., 2013; Kim et al., 2007; Pendeville et al., 2008; Villa et al.,
2001; Yamamizu et al., 2010; Herzog et al., 2001). Furthermore,
the ETS1 and CD93 markers associated with the HSC program
expressed across all endothelial populations captured in this da-
taset (Figure S5B; Bertrand et al., 2005; Park et al., 2018; Ciau-
Uitz et al., 2013; Taoudi et al., 2005). CL9, expressing the
erythroid marker GYPA and the embryonic/fetal hemoglobins
HBE1, HBZ, and HBA2, represents primitive erythroid progeni-
tors (Figures 4C and 4E).
Analysis of Lineage Relationships
Two CLs adjacent to the endothelial network represent the he-
matopoietic lineage (CL10 and CL11; Figure 4B). The small
CL10 immediately attached to the endothelial network is the
HSPC population co-expressing endothelial and hematopoietic
CDH5+PTPRC+(CD45+) determinants (Figure 4C), marked by
the transcription enhancer gene NCOA7 identified in our HSPC
signature (Figures S5A and 3C). HSPC CL10 is directly linked
to amoremature hematopoietic CL11with simultaneous PTPRC
up- and CDH5 downregulation (Figures 4C and 4D). Intriguingly,
PAGA most confidently links HSPC CL10 with APLNR+-
COUPTFII+RUNX1 CL5, making it the most likely candidate
for hematogenic endothelium (Figure 4D). The HSPC population
shows downregulation of venous markers and minimal arterial
marker expression (GJA5 and HEY2). The force-directed graph
also indicates a lineage relationship between arterial CL1 and
CL5, suggesting that CL5 is a ‘‘bridge’’ population between the
arterial endothelium and hematopoietic populations (Figure 4D).
The non-arterial signature of CL5 likely reflects COUP-TFII-medi-
ated downregulation of Notch signaling, required for HSC matu-
ration (Tang et al., 2013; Lizama et al., 2015; Souilhol et al.,
2016b; Gama-Norton et al., 2015; You et al., 2005). Notably,
CL5 is enriched for cell cycle-related pathways (Data S3) associ-
ated with elevated expression of TOP2A, PCNA, and CDK1 (Fig-
ure S5C). This is in line with the previous finding that EHT toward
mature mouse HSCs is accompanied by activation of prolifera-
tion (Batsivari et al., 2017). Additional single-cell analysis of
limited cell numbers from a second CS16 embryo also showed
a lineage relationship betweenCOUP-TFII endothelium (CDH5+-
PTPRC) and HSPCs (CDH5+PTPRC+) (Figure S5D).Cell Population-Specific Resolution Suggests Autocrine
and Paracrine Endothelin 1 Action
To identify source populations of ventrally enriched secreted fac-
tors detected above, all such V_Inner/Mid factors (LCM-seq2)
were mapped onto the CS16 AoV single-cell dataset (Figure 5A).n Using Single-Cell RNA-Seq Analysis
(AoV) and D (AoD) domains. CD34+ cells were bead purified from the AoV cell
,379 single cells). Hem, hematopoietic; HSPC, Hem stem/progenitor cell; SNS,
ks with large arterial (GJA5+) CL1 and HSPC cluster 10 (CL10), which transits
ia the bridge CL5 with a downregulated arterial signature (evident from force-
.
A) topology tree of cells from (B), excluding CL17–CL20. Note that HSPC CL10
and downstreammature blood cells (CL.11), highlighted by asterisks. Thewidth
ormalized).
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Figure 5. Mapping LCM-Seq Niche Signals to Cell Populations in the AoV Suggests Autocrine and Paracrine Signaling of Endothelin 1
(A) Expression of differentially expressed secreted factors detected in the V_Inner and V_Mid subdomains (LCM-seq1) in cell CLs shown in Figure 4B.
(B) Mapping expression of endothelin and renin core pathway genes on the CS16 AoV single-cell dataset (the plot is ln normalized).
(C) Mapping expression of CXCR4 and CXCL12 to cell CLs shown in Figure 4 (the plot is ln normalized).
(D) StringDB network of high-confidence known and predicted interactions between genes expressed in arterial CL1, including direct protein-protein physical and
indirect functional associations (confidence > 0.7). The size of a node indicates the number of connecting edges. The width of a line indicates confidence of the
interaction; confidence levels = 0.4–0.9.
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ResourceWe found that the hematopoietic CL11 has highest expression of
SPP1 involved in adult HSC migration and proliferation (Nilsson
et al., 2005) and complement factor C1QA, in line with expres-830 Cell Stem Cell 27, 822–839, November 5, 2020sion in the V_Hem population (hematoendothelial dataset; Fig-
ure 3B; Data S2). The endothelial CL8 produces the metallopro-
teinase ADAMTS1 and chemokines CCL2 and CXCL2 with
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Resourcepotential to recruit monocytes and other immune cells to the AoV
(Ajuebor et al., 1998). Pericytes (CL14) secrete the Wnt signaling
modulator FRZB (Cruciat and Niehrs, 2013), the inhibitor of
transforming growth factor b (TGF-b) and BMP signaling LEFTY2
(Ulloa and Tabibzadeh, 2001), as well as TINAGL1 and MFAP4.
Epithelial EPCAM+ CL19 is a source of HSD11B1L and the plas-
minogen activator PLAT. Additionally, the top ventrally polarized
endothelial genes GATA4 and FGF23 from the hematoendothe-
lial sort dataset (V_Endo versus D_Endo) were markedly ex-
pressed in the endothelial CL8 (Figure S5A), indicating its poten-
tial significance in the HSC niche.
Most components of the renin-angiotensin pathway are not
detectable in the single-cell dataset, except for the angiotensin
receptor AGTR2, localized to the arterial CL1, and prorenin re-
ceptor ATP6AP2 global expression, particularly high in CL19
(Figure 5B). Although EDN1 localized broadly in the endothelial
central network with particularly high and consistent expression
in CL1, CL4, and CL7, the strongest ECE1 (activating enzyme)
expression indicates that arterial CL1 is themain source of active
endothelin 1 (Figure 5B). Furthermore, the chemokine CXCL12
and its receptorCXCR4, involved in HSC development and func-
tion, are expressed in CL1 (Figure 5C; Lapidot and Kollet, 2002;
Wright et al., 2002; Sugiyama et al., 2006). CL1 is also a strong
source of Notch ligands (DLL4, JAG1, and HEY2) (Figure S5A).
Co-expression of all these markers indicates the importance of
arterial endothelium in the developing HSC niche (Hadland
et al., 2015). Expression of the endothelin receptor EDNRA is
mainly confined to the mesenchymal populations (CL12–CL15),
whereas EDNRB is expressed mostly in the arterial endothelial
CL1 and hematopoietic CL11, consistent with expression in
the V_Endo and V_Hem fractions. Thus, endothelin 1 signaling
emanating from the Ao endothelial lining potentially acts in an au-
tocrine and paracrine (mesenchymal and hematopoietic)
manner. Notably, StringDB interactome analysis of CL1 places
EDN1 in the center, connecting it with other central signaling
molecules: FOS, MMP2, PTGS2, and CXCR4 (Figure 5D).
Hotspots of Endothelin 1 Expression Correlate with
Localization of IAHCs
EDN1 and REN expression patterns were analyzed at the RNA
and protein levels using RNAScope and immunofluorescence.
Despite high REN expression in the [V]+[VL] subdomains
(LCM-seq1) and the V_Mid subdomain (LCM-seq2), it was de-
tected only in occasional cells immediately below the ventral
endothelium (Figure 6A). However, higher REN expression was
observed along the vessels branching ventrolaterally from the
Ao toward the mesonephros (Figure 6B). Hematoendothelial
cells are potential targets for REN because of expression of
the receptor ATP6AP2 (Figure 3F).
Despite EDN1 expression by endothelial cells across the entire
D-V axis (Figures 6A and 6D’’), some endothelial cells had a
higher density of the EDN1 probe making a signal cluster (>300
pixels/2,0483 2,048 pixel image), referred to as EDN1 hotspots
(Figures 6C–6E). Quantification determined significantly more
EDN1 hotspots in the AoV compared with the AoD (paired t
test, p < 0.01), in line with EDN1 enrichment in sorted ventral
endothelium (Figure 6E). Furthermore, EDN1 hotspots are
frequently located proximal to Runx1+ cells or IAHCs with strong
statistical correlation (Figures 6C, 6D, and 6G). Some lowerEDN1-expressing mesenchymal cells were also detected below
IAHCs (Figure 6Ai). This suggests that high EDN1 expression
near IAHCs may play a role in HSPC development.
Notably, immunostaining detected a strong EDN1 protein
presence in IAHCs (Figures 6F andS6A). Because our population
and single-cell analyses showed only minimal EDN1 mRNA
expression in HSPCs (Figures 3F and 5B), we assume seques-
tering of external EDN1 protein onto emerging IAHCs through re-
ceptor binding. Indeed, low EDNRA levels were detected within
IAHCs, in line with moderate expression in HSPCs (Figures 3F
and S6B), in addition to broad expression in the mesenchyme
(Figures 5B, CL12–CL15); 6D’’, and S6C). Although we cannot
fully exclude autonomous EDN1 expression within IAHCs, this
is unlikely to be due to predominant association of EDN1 immu-
nostaining with the cell membrane and not with the cytoplasm.
The receptor EDNRB was not detectable in IAHCs but observed
frequently in single budding cells (Figure S6A) and weakly in the
endothelium. Strong EDNRB expression was observed in pre-
sumably ventrally migrating neural crest derivatives (Figures
6D’’ and S6C; Nataf et al., 1996). Some EDNRB+ cells can be
macrophages of hematopoietic CL10 (single-cell dataset;
Figure 5B).
Endothelins Enhance Hematopoietic Development in
the Mouse and Human Systems
We first investigated whether endothelin signaling can promote
adult-type hematopoiesis using the mouse model. Previous
spatial transcriptome analysis determined that mouse Ren1
was ventrally enriched in embryonic day 9.5 (E9.5) and E10.5
AoV but Edn1 in E9.5 AoV only (Figure S7A; McGarvey et al.,
2017). The similar isoform Edn2, ventrally enriched at E9.5 and
E10.5 (which differs from Edn1 by 3 amino acids only), was
included in the functional analysis. As in the human, ventral hot-
spots of Edn1mRNAwere detected proximal to emerging IAHCs
(Figure S7B). Similarly, EDN1 protein was detected on CD31+-
cKit+ IAHCs (E10.5), mainly on cell membranes exposed to the
Ao lumen, and excluded from cell-cell contact interfaces, sug-
gesting sequestering via receptors (in contrast to CD31 and
cKit) (Figure 7A). Weaker EDN1 staining was also observed
throughout the subaortic mesenchyme.
To establish whether endothelin signaling can promote adult-
type hematopoiesis, we used an ex vivo system recapitulating
HSC development (Rybtsov et al., 2014; Figure 7B). Reaggre-
gates of E9.5 caudal tissues were cultured on floating mem-
branes with addition of one of the factors REN1, EDN1, or
EDN2 (each in two concentrations: 10 and 100 ng/mL). After
7 days, reaggregates were plated in a colony-forming (CFU-C)
assay. Although total CFU-C numbers did not change markedly
(Figure 7C), each factor significantly shifted CFU-C production
from CFU-Macs to more immature CFU-GEMMs (in a dose-
dependent manner for EDN1 and EDN2, Fisher’s test, p <
0.001) (Figure 7D).
Reaggregate cultures were also transplanted into irradiated
Ly5.1 mice, and hematopoietic (CD45_2) repopulation was as-
sessed at 8 and 18weeks (3 experiments) (Figure 7E). All 3 factors
enhanced long-term multilineage repopulation in the peripheral
blood, spleen, and bonemarrow compared with controls (statisti-
cally significant for REN [100 ng/mL] and EDN2 100 ng/mL],
p < 0.05, paired t test) (Figures 7E and S7C–S7F).Cell Stem Cell 27, 822–839, November 5, 2020 831
Figure 6. Endothelin-1 Expression Highly Correlates with Localization of IAHCs
(A) Expression overlap between EDN1, CDH5, and REN1. The arrowhead indicates a REN1+ cell below the CDH5+ endothelium. The images in (Ai) show a
magnification of the boxed region in (A).
(B) Expression of REN+ cells enveloping the endothelium of an Ao V branching vessel (BV) directed toward the Mn. The images in (Bi) show amagnification of the
boxed region in (B).
(C and D) Immunostaining highlighting V CDH5+Runx1+CD45+ IAHCs (C’ and D’) and, on the sister section, a higher EDN1 signal in a corresponding position (C’’
and D’’). Arrowheads indicate positions of IAHCs.
(E) Representative binary image of EDN1 expression across the Ao with EDN1 hotspots (pixels > 300, 2,0483 2,048 pixel image) numbered and outlined in red. A
line divides the AoD (top) from the AoV (bottom). The box-and-whisker plot shows the percentage of EDN1 hotspots found in the AoV or AoD in each section (n =
14). p < 0.01, t test.
(F) CL of rounded EDN1-expressing cells attached to the CDH5+ endothelial lining (arrows). Images in (Fi) show a magnification of the boxed region in (F).
(G) Correlation between the position of Runx1+ IAHCs in each section with the position of EDN1 hotspots (R, correlation coefficient).
For (A)–(C), (E), and (F), protein or RNA expression is indicated by non-italicized and italicized names, respectively. SMA, superior mesenteric artery. The D-V axis
is indicated. Images show transverse sections of CS15–CS16 embryos. Scale bars, 50 mm.
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Figure 7. Endothelins Promote Hematopoiesis in the Mouse and Human Model Systems
(A) CD31, cKit, and EDN1 immunostaining in the Ao of an E10.5 mouse embryo. Arrowheads indicate cKit+EDN1+ IAHCs or individual emerging Hem cells. The
images in (A’’) show a magnification of the boxed region in (A’). Scale bars: 50 mm.
(B) Experimental strategies for mouse and human model systems. MC, methocult.
(legend continued on next page)
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ResourceWe then explored the effects of endothelin on human hemato-
poietic development. Because human AGM region cultures
showed limited potential for analysis of HSC development (East-
erbrook et al., 2019), we employed human embryonic stem cells
(hESCs), used broadly to model hematopoietic development
(Figure 7B). In contrast to the mouse, EDN1 was differentially ex-
pressed in the human HSC niche (EDN2 showed no expression
and was not used for analysis).
hESCs were cultured as described previously (Ng et al., 2016).
At day 8, during induction of hematogenic endothelium, individ-
ual cultures were supplemented with 100 ng/mL EDN1, 1 nM
EDNRA inhibitor, or 100 nM EDNRB inhibitor. Within 4 days,
5,000 cells from each culture were plated in duplicates in meth-
ylcellulose culture, and colonies were scored 14 days later. We
found that EDN1 significantly increased CFU-C production
compared with control cultures, including a significant increase
in complex CFU-GEMM colonies (paired t test, p < 0.01) (Figures
7F and 7G). Some reductions in total CFU-C numbers supple-
mented with EDNRA and EDNRB inhibitors were not significant.
DISCUSSION
Developing HSCs are embedded in and influenced by the highly
heterogeneous molecular milieu of the AGM region. Like many
other developmental processes, HSC development is under-
pinned by embryonic inductive interactions and cross-signaling
between adjacent tissues and regions. Although model organ-
isms provide valuable insights into the mechanisms underlying
hematopoietic development, these cannot be extrapolated
directly to humans because of the specifics of hematopoietic
development (Easterbrook et al., 2019).
We transcriptionally profiled sorted Ao hematoendothelial
populations (endothelial cells, HSPCs, and mature blood cells)
that allowed us to track signaling dynamics during EHT. To
further increase resolution, we performed single-cell RNA-seq
analysis, which revealed rich cellular heterogeneity within the
Ao. We identified a central endothelial network consisting of 5
populations expressing venous markers (APLNR+, COUP-
TF2+) with a loosely connected large arterial CL (GJA5+,
HEY2+, and upregulated Notch signaling). The CDH5+CD45+
HSPC population (Ivanovs et al., 2014) was closely associated
with the central endothelial network and, unexpectedly, was indi-
rectly linked to the arterial CL via a bridging endothelial popula-
tion with a downregulated arterial signature. Many previous
studies have recognized the close relationship between arterial
and hematopoietic developmental programs (Clements and Tra-
ver, 2013; Park et al., 2018)). This bridging population showed
increased proliferation, in line with previously reported activation
of proliferation during HSC maturation in the mouse (Batsivari(C) Production of CFU-Cs in E9.5 caudal tissues cultured with each of the test fa
experiments.
(D) Proportion of CFU-Mac and CFU-GEMM from (B), normalized to 1; n = 4 inde
(E) Repopulation with E9.5 caudal part cells cultured with the test factors (REN1, ED
n = 3 independent experiments). The shape on the graph indicates the experiment
of long-term repopulating mice (18 weeks) higher than 1% are as follows: CTR
EDN2_10, 2/11; EDN2_100, 6/12.
(F) Effect of test factors on production of CFU-Cs by human ES cells at 12 days of
factors were added at day 8 of culture (**p < 0.01, paired t test; error bars, ± SE
(G) Production of CFU-GEMM from (E) (**p < 0.01, paired t test; error bars, ± SE
834 Cell Stem Cell 27, 822–839, November 5, 2020et al., 2017) suggesting similarity to the bridging population
with mouse pro/pre-HSCs (Taoudi et al., 2008; Rybtsov et al.,
2011, 2014). Downregulation of arterial markers in the bridging
population is likely a consequence of downregulation of NOTCH
signaling (described as a prerequisite for HSC/IAHC maturation
in themouse), probably because of upregulation of COUP-TFII (a
Notch suppressor) observed in our dataset (Lizama et al., 2015;
Bos et al., 2015; Souilhol et al., 2016b; Tang et al., 2013; Richard
et al., 2013; Gama-Norton et al., 2015; You et al., 2005).
Our observation is in line with evidence that hESC-derived
hematogenic endothelium is negative for arterial (KDR) and
venous (NT5E) markers and emerges separately from the arterial
endothelium (Ditadi et al., 2015). It is likely that the recently pro-
posed arterial origin of hematogenic endothelium at CS13 (Zeng
et al., 2019) can be explained by exclusion of venous cells from
analysis. Notably, the cells in our dataset expressing venous
markers also expressed classical arterial markers, including neu-
ropilin 1 (NRP1) and SOX17 (Herzog et al., 2001; Corada et al.,
2013). In the early mouse Ao, some cells also co-express arterial
and venous markers (Lindskog et al., 2014). The distinction be-
tween arterial and venous identity during embryogenesis is
therefore less defined than usually presumed.
We interrogated human HSC developmental niche signaling
using spatial transcriptomics to map ventrally polarized signals
potentially associated with IAHCs/HSCs emergence. Signaling
in close proximity to IAHCs/HSCs included some known path-
ways involved in HSC development: TNF-a signaling via NF-kB
(Espı́n-Palazón et al., 2014), MTORC1 signaling (Zhou et al.,
2016), and NO signaling (North et al., 2009; Adamo et al.,
2009). Here we decided to focus on the ventrally enriched car-
diac EGF pathway, which was not implicated previously in
HSC development. A major regulator of this pathway, EDN1
(which also contributes to TNF-a signaling via NF-kB), showed
strong ventral polarization. Interactome analysis revealed a
high number of endothelin 1 interactions with other niche factors,
suggesting its key role in the developing HSC niche. Our ana-
lyses also revealed ventral polarization of renin along with other
components of the renin-angiotensin pathway, which has a
known reciprocal relationship with endothelin 1 (Beierwaltes
and Carretero, 1992; Lin et al., 1993; Ackermann et al., 1995;
Rossi et al., 1999). Based on these data, we focused on investi-
gation of endothelin 1 and renin functions in HSPC development.
Functional analysis in the mouse system demonstrated a
strong influence of endothelin signaling on hematopoietic devel-
opment because EDN1 and EDN2 increased the number of early
multipotent progenitors (CFU-GEMM) in E9.5 caudal tissue
ex vivo (Rybtsov et al., 2014). Importantly, addition of EDN2
(and REN1) substantially stimulated mouse HSC development.
Furthermore, using the hESC culture system, we demonstratedctors (REN1, EDN1, and EDN2) at 10 ng/mL and 100 ng/mL. n = 4 independent
pendent experiments.
N1, and EDN2) and 18weeks following transplantation (*p < 0.05, paired t test,
. The red line shows the upper limit of control repopulation levels). The numbers
L, 0/11; REN1_10, 3/11; REN1_100, 5/12; EDN1_10, 3/11; EDN1_100, 3/12;
differentiation. The number of day 14 CFU-Cs per 5,000 plated cells is shown;
M, n = 4).
M).
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Resourcethat EDN1 (the major isoform in the human AGM region) signifi-
cantly increased production of early multipotent hematopoietic
progenitors at the expense of unipotent CFU-M. Collectively,
these experiments show that endothelins are important regula-
tors of HSC development in humans.
Our transcriptome analyses provided some insight into poten-
tial mechanisms of endothelin action. EDN1 is expressed mainly
by endothelial fractions and mature blood cells. However, to
become active, it requires processing with the maturation factor
ECE1, which is expressed mainly by the arterial CL, suggesting
that it is the main source of active EDN1 in the niche. Here
EDN1 is well positioned to signal to all main constituents of the
niche. The hotspots of EDN1 discovered in this study immedi-
ately adjacent to IAHCs/HSCs can directly influence emerging
HSPCs and single cells budding into the lumen through EDNRA
and EDNRB, respectively. Additionally, EDN1 may act on HSC
development indirectly, via other AGM populations that express
endothelin receptors, including endothelium, pericytes, mesen-
chymal cells, the neural crest, and macrophages. For example,
EDNRB+ ventral endothelial cells might mediate EDN1 action,
being in immediate contact with developing HSCs. Of note, the
most significantly upregulated TF in the ventral endothelium,
GATA4, is induced by endothelin 1 in response to increased
blood pressure (Hautala et al., 2001; Kitta et al., 2001). This rai-
ses the possibility that GATA4 can be involved in EHT stimulation
by shear stress (Adamo et al., 2009; North et al., 2009).
Combined transcriptome analysis revealed many other
secreted factors that would be worth exploring further. One
such example is SPP1, which has a documented role in the fetal
and adult bone marrow, modulating HSC proliferation and
migration (Nilsson et al., 2005; Cao et al., 2019; Stier et al.,
2005), and binds CD44, recently implicated in EHT (Luo et al.,
2011; Oatley et al., 2020). Our population and single-cell analysis
showed that SPP1 is mainly generated by hematopoietic popu-
lations, perhaps by macrophages (Lund et al., 2009).
In conclusion, our study not only identifies important regula-
tors of HSC development in humans but also provides a valuable
resource for the community for in-depth investigation of mecha-
nisms underlying development of the adult hematopoietic sys-
tem in humans. Exploration of multiple heterogeneous cell pop-
ulations as described here may inform new protocols for human
HSC derivation from pluripotent cells for clinical applications.
Limitations of Study
Because of the rarity of human embryonic tissues, the sample
numbers in this study are lower than optimal. Therefore, func-
tional validation of secreted factors was performed using mouse
embryo ex vivo and hESC in vitro models. Although significant,
transplantation results between experiments are variable, likely
reflecting natural heterogeneity and heterochrony in hematopoi-
etic development between embryos (Taylor et al., 2010). Further
analysis of direct endothelin 1 effects on human HSC develop-
ment in vivomay become possible in the futurewhen appropriate
approaches become available.
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Teillet, M.A., Vincent, C., Rosselló Castillo, C., Torres, M., et al. (2013).
Endothelio-mesenchymal interaction controls runx1 expression and modu-
lates the notch pathway to initiate aortic hematopoiesis. Dev. Cell 24, 600–611.
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Antibodies
Mouse monoclonal anti-CD144 BD Biosciences Cat# 555661, RRID:AB_396015
Sheep polyclonal anti-CD31/PECAM1 R and D Systems Cat# AF806, RRID:AB_355617
Rabbit monoclonal anti-RUNX1 Abcam Cat# ab92336, RRID:AB_1580795
Mouse monoclonal anti-CD45 BD Biosciences Cat# 555480, RRID:AB_395872
Rabbit monoclonal anti-Renin Abcam Cat#ab212196, Clone:EPR20693
Mouse monoclonal anti-Endothelin 1 Abcam Cat# ab2786, RRID:AB_303299
Mouse monoclonal anti- Endothelin A
Receptor
R and D Systems Cat# MAB65381, Clone:485709
Rabbit polyclonal anti-Endothelin B
Receptor
Abcam Cat# ab117529, RRID:AB_10902070
Rat monoclonal anti-CD31/PECAM1 Biolegend Cat#102501, RRID:AB_312908
Goat polyclonal anti-c-Kit R and D Systems Cat# AF1356, RRID:AB_354750
Rabbit polyclonal anti-Endothelin 1 Abcam Cat# ab117757, RRID:AB_10901366
Donkey polyclonal anti-Sheep IgG NL557 R and D Systems Cat# NL010, RRID:AB_884220
Goat polyclonal anti-Mouse IgG
(H+L) AF488
Thermo Fisher Scientific Cat# A-11001, RRID:AB_2534069
Donkey polyclonal anti-Rabbit IgG
(H+L) AF647
Abcam Cat# ab150075, RRID:AB_2752244
Goat polyclonal anti-Rat IgG (H+L) AF546 Thermo Fisher Scientific Cat# A-11081, RRID:AB_2534125
Donkey polyclonal anti-Goat IgG
(H+L) AF488
Thermo Fisher Scientific Cat# A-11055, RRID:AB_2534102
Mouse anti-CD45.1, V450 Conjugated,
Clone A20
BD Biosciences Cat# 560520, RRID:AB_1727490
Mouse anti-CD45.1 APC Conjugated,
Clone A20
Thermo Fisher Scientific Cat# 17-0453-82, RRID:AB_469398
Mouse anti-CD45.2 V500 Conjugated,
Clone 104
BD Biosciences Cat#562129, RRID:AB_10897142
Mouse anti-CD45.2, PE Conjugated,
Clone 104
Thermo Fisher Scientific Cat# 12-0454-82, RRID:AB_465678
Rat anti-CD45R, APC-Cy7 Conjugated,
Clone RA3-6B2
BD Biosciences Cat# 552094, RRID:AB_394335
Armenian Hamster anti-CD11c, PE/Cy7
Conjugated, Clone N418
BioLegend Cat# 117317, RRID:AB_493569
Rat anti-TER119, FITC Conjugated Thermo Fisher Scientific Cat# 11-5921-82, RRID:AB_465311
Rat anti-Ly-6G/Ly-6C, PE Conjugated,
Clone RB6-8C5
Thermo Fisher Scientific Cat# 12-5931-81, RRID:AB_466044
Rat anti-CD335, BV711 Conjugated,
Clone 29A1.4
BioLegend Cat# 137621, RRID:AB_2563289
Armenian Hamster anti-CD3e, APC
Conjugated, Clone 145-2C11
Thermo Fisher Scientific Cat# MA1-10186, RRID:AB_11153519
Rat anti-CD4, APC Conjugated,
Clone GK1.5
Thermo Fisher Scientific Cat# MA1-10218, RRID:AB_11152647
Mouse Anti-HumanCD144, PEConjugated,
Clone TEA 1/31
Beckman Coulter Cat# A07481
Mouse Anti-Human CD45 Monoclonal
Antibody, V450 Conjugated
BD Biosciences Cat# 560368, RRID: AB_1645574
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Mouse Anti-CD235a Monoclonal Antibody,
Allophycocyanin Conjugated, Clone GA-
R2 (HIR2)
BD Biosciences Cat# 551336, RRID:AB_398499
Rat anti-CD8a, BV711 Conjugated, Clone
53-6.7
BioLegend Cat# 100747, RRID:AB_11219594
Chemicals, Peptides, and Recombinant Proteins
Tissue-Tek O.C.T. Compound VWR Cat# 25608-930
Hematoxylin Solution, Mayer’s Sigma-Aldrich Cat# MHS32-1L
Eosin Y Solution Sigma-Aldrich Cat# HT110216
Diethyl pyrocarbonate Sigma-Aldrich Cat# 40718
RNaseAWAY  Sigma-Aldrich Cat# 83931
Recombinant RNase Inhibitor Takara Cat# 2313B
10mM dNTP mix Thermo Fisher Scientific Cat# 18427013
SuperScript IV Reverse Transcriptase Thermo Fisher Scientific Cat# 18090010
KAPA HiFi HotStart ReadyMix Roche Cat# KK2601
Nuclease-Free Water (not DEPC-Treated) Thermo Fisher Scientific Cat# AM9939
ProLong Gold Antifade Mountant Thermo Fisher Scientific Cat# P36930
DAPI Solution Thermo Fisher Scientific Cat# 62248
Opal 520 Perkin Elmer Cat# FP1487001KT
Opal 570 Perkin Elmer Cat# FP1488001KT
Opal 690 Perkin Elmer Cat# FP1497001KT
Collagenase/Dispase Roche Cat# 10269638001
DNase I recombinant Roche Cat# 4716728001
IMDM Thermo Fisher Scientific Cat# 21980032
DPBS, calcium, magnesium Thermo Fisher Scientific Cat# 14040091
HyClone Fetal Bovine Serum, South
American Origin
Fisher Scientific Cat# 10309433
Human Endothelin-1 Sigma-Aldrich Cat# E7764
Methocult H4034 Optimum StemCell Technologies, Inc. N/A
MethoCult GF M3434 StemCell Technologies, Inc. N/A
Mouse recombinant Endothelin 1 LSBio Cat# LS-G26630-10
b-Endothelin mouse (Endothelin 2) Sigma-Aldrich Cat# SCP0259
Mouse recombinant Renin Sigma-Aldrich Cat# SRP6266
mTeSR1 Complete Kit – GMP StemCell Technologies, Inc. Cat# 85850
ACCUTASE StemCell Technologies, Inc. Cat# 07922
STEMdiff APEL2 StemCell Technologies, Inc. Cat# 05270
Recombinant Human BMP-4 Protein R and D Systems Cat# 314-BP
Recombinant Human/Mouse/Rat Activin A
Protein
R and D Systems Cat# 338-AC
Human VEGF 165 Peprotech Cat# 100-20
Human EPO Peprotech Cat# 100-64
Human FGF-basic Peprotech Cat# 100-18B
Human IGF-II Peprotech Cat# 100-12
Human IL-3 Peprotech Cat# 200-03
Human IL-6 Peprotech Cat# 200-06
Human SCF Peprotech Cat# 300-07
Human TPO Peprotech Cat# 300-18
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Y-27632 dihydrochloride R and D Systems Cat# 1254
SB431542 Cayman Chemicals Cat# 13031
Chir99021 Tocris Biosciences Cat# 4423
Critical Commercial Assays
PicoPure RNA Isolation Kit Thermo Fisher Scientific Cat# KIT0204
SMARTer Stranded Total RNA-Seq Kit v2 -
Pico Input Mammalian
Takara Cat# 634412
CD34 MicroBead Kit, human Miltenyi Biotec Cat# 130-046-702
RNAScope Multiplex Fluorescent Reagent
Kit v2
ACD, Biotechne Cat# 323100
Deposited Data
RNA-Seq Raw Data for LCM-Seq, Bulk and
Single-cell datasets
This paper GEO: GSE151877
Experimental Models: Cell Lines
ES Cells H9 N/A
OP9 Cells N/A
Experimental Models: Organisms/Strains
C5BL/6(CD45.2/2) mice N/A
C57BL/6 CD45.1/2 N/A
Oligonucleotides
oligodT (50-AAGCAGTGGTATCAACGCA
GAGTACTTTTTTTTTTTTTTT
TTTTTTTTTTTTTTTVN-30)
IDT N/A
TSO-LNA-oligo (50- AAGCAGTGGTATCAA
CGCAGAGTACATrGrG+G 30)
Exiqon N/A
ISPCR primers (50 - AAG CAG TGG TAT
CAA CGC AGA GT – 30)
IDT N/A
Software and Algorithms
R (R-3.2.3 – R-3.6.1) The R Foundation https://www.r-project.org
Cellranger (v2.1.0) 10X Genomics https://support.10xgenomics.com
FastQC Andrews, 2010 N/A
Flexbar Dodt et al., 2012 N/A
STAR Dobin et al., 2013 N/A
SAMtools Li et al., 2009 N/A
Multicov, BEDtools Quinlan and Hall, 2010 N/A
DESeq2 Love, Huber and Anders, 2014 N/A
ggplot2 Wickham, 2019 https://ggplot2.tidyverse.org/
EnhancedVolcano https://github.com/kevinblighe/
EnhancedVolcano
GSEA software Subramanian et al., 2005, 2007;
Broad Institute
N/A
String-DB Szklarczyk et al., 2019 https://string-db.org/
Cytoscape software Shannon et al., 2003 N/A
EnrichmentMap https://www.baderlab.org/Software/
EnrichmentMap
CellPhoneDB v2.0 Efremova et al., 2020 N/A
Loompy https://github.com/linnarsson-lab/loompy
SCANPY Wolf et al, 2018 N/A
Partition-based graph abstraction (PAGA) Wolf et al., 2019 N/A
scVelo https://github.com/theislab/scvelo
(Continued on next page)
ll
Resource
e3 Cell Stem Cell 27, 822–839.e1–e8, November 5, 2020
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Other
RNAScope Probe: Hs-EDN1 ACD, Biotechne Cat# 459381
RNAScope Probe: Hs-EDNRA-C2 ACD, Biotechne Cat# 443661-C2
RNAScope Probe: Hs-EDNRB-C3 ACD, Biotechne Cat# 528301-C3
RNAScope Probe: Hs-REN-C3 ACD, Biotechne Cat# 401921
RNAScope Probe: Hs-CDH5-C2 ACD, Biotechne Cat# 437451-C2
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Lead Contact
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, Alexander
Medvinsky (A.Medvinsky@ed.ac.uk).
Materials Availability
This study did not generate new unique reagents.
Data and Code Availability
The accession number for the RNA-Sequencing raw data reported in this paper is GEO: GSE151877.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human embryonic material
Humanembryonic samplesofCarnegieStages15–17wereprovidedby theMRCCentre forReproductiveHealthandby theJointMRC/
Wellcome (MR/R006237/1) Human Developmental Biology Resource (https://www.hdbr.org/). This study was approved by the Lothian
ResearchEthicsCommittee.Theembryoswereobtained immediatelyafter elective terminationofpregnancy forwhicheachpatientgave
informed consent in writing. Embryos were either used immediately as fresh tissue or flash frozen inOptimal Cutting Temperature (OCT)
compound and stored at80C. Human embryo karyotypes: CS17N2-3 (LCM-Seq1): 46,XY; CS16 N1-N3 (LCM-Seq2) + CS15 (FACS
sorted): rsa(13,15,16,18,21,22)X2,(X,Y)X1; CS17 N1 (LCM-Seq1) + CS16 (FACS sorted) + 2x CS16 (Single-cell RNA-Seq): Unknown.
Mouse models
All mouse experiments were performed under a Project License granted by the Home Office (UK), University of Edinburgh Ethical
Review Committee, and conducted in accordance with local guidelines. Animals were housed within the University of Edinburgh
adhering to the Animals Scientific Procedures Act, UK, 1986. All mouse experiments were carried out by researchers with a personal
license granted by the Home Office. Mice were kept in stable light cycling conditions (14 hours light and 10 hours dark) with a regular
supply of chow food and water. Embryos were used from C57BL/6 (CD45.2/2) (Jackson Laboratories) mice and C57BL/6-Ly5.1
(CD45.1) mice were used as hosts for transplantation experiments.
To obtain embryos of the correct stage paired matings were set up and the morning of discovery of a vaginal plug is considered
embryonic day (E) 0.5. The embryos were collected at E9.5. Following schedule 1 culling of the pregnant dam, the uterine horns were
removed and the embryos dissected out of the extra-embryonic tissues including the yolk-sac and the amniotic sac. The embryos
were then more accurately staged by counting the somite pairs (SPs) (E9.5 = 25 29 SPs). The caudal parts were taken which in-
cludes everything below the heart.
Cell lines
The H9 human embryonic stem (ES) cell line was used in ES differentiation experiments and maintained in mTeSR1 (StemCell Tech-
nologies, Inc.) on Biolaminin 521 (BioLamina) coated wells at 37C and 95% humidity in an atmosphere of 5% CO2. Media was
changed daily and cells were passaged every 4-5 days using 1x Accutase (Sigma-Aldrich) for dissociation.
OP9 cells were used in co-aggregates with mouse E9.5 primary cells. They were maintained in Iscove’s modified Dulbecco’s me-
dium (IMDM, Invitrogen), 20% Foetal Calf Serum (FCS, GIBCO), L-glutamine (4 mM) and penicillin/streptomycin (P/S, GIBCO) (50 U/
ml) at 37C and 95% humidity in an atmosphere of 5% CO2.
METHOD DETAILS
Laser Capture Microdissection
Human embryos embedded in OCT stored at 80C were equilibrated to 24C and sectioned in a caudal-to-rostral direction
using a cryotome FSE cryostat (Thermo Scientific). Frequent checks under the microscope verified the level reached along theCell Stem Cell 27, 822–839.e1–e8, November 5, 2020 e4
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onto nuclease-free polyethylene napthalate (PEN) membrane slides (Zeiss). At intervals, a sister section would be transferred to a
SuperFrost slide for future validation of ventral IAHCs by immunohistochemical analysis. Sections were stained using a rapid Hae-
matoxylin and Eosin staining protocol - 3 minutes (min) in 70% ethanol, 1 min H2O, 4 min Mayer’s Haematoxylin Solution (Sigma-
Aldrich), 2 min tap H2O, 15 s Eosin Y (Sigma-Aldrich), 1 min 70% ethanol, 1 min 90% ethanol, 3 mins 100% ethanol. All H2O was
treated with diethyl pyrocarbonate (DEPC) and all reagents were pre-cooled in ice except 100% ethanol which was room
temperature.
The laser capture microscope used was the PALMmicrobeam (Zeiss). The microscope and surrounding area were sprayed down
with RNaseAWAY  (Sigma-Aldrich). Sections were viewed and microdissected in brightfield using a 10X objective. The microdis-
sected regions were collected into the caps of AdhesiveCap 500 opaque (Zeiss) 500ml PCR tubes. 15ml lysis buffer (0.2%Triton X-100
(Sigma-Aldrich), 2U/ml RNase inhibitor (Takara), Phosphate Buffer Solution (PBS; Nichterwitz et al., 2016) was added directly on top
of the dissected tissue in the tube caps and the tubes closes in an inverted position.
Human embryo cell sorting
The dorsal aortas were dissected from human embryos CS15-16 (N = 2) then further bisected into ventral and dorsal portions (AoV
and AoD respectively). Tissues were dissociated into single cells in 1mg/ml Collagenase-Dispase (Roche) and 0.12 mg/ml of DNase I
(Roche) for 35 min in a 37C rotating water bath and stained with conjugated antibodies anti-human VE-Cadherin-PE (Beckman
Coulter, 5mg/ml), anti-human CD45 –v450 (Clone: HI30, BioLegend, RRID:AB_1645574, 6mg/ml) and anti-human CD235A – APC
(BD Bioscience, RRID:AB_398499, 0.2mg/ml) for 1 hour at 4C. Dead cells and erythroid cells were excluded by 7AAD and
CD235A staining respectively. VC+CD45-, VC+CD45+ and VC-CD45+ populations were sorted using a FACS Aria-II (BD Bioscience)
into Eppendorf tubes containing RLT buffer from the RNeasy Micro kit ready for RNA purification. Data acquisition and analysis was
performed using FlowJo software (Tree Star).
For the 10X single cell sequencing, following AoV cell dissociation, CD34+ cells were isolated using the human CD34 MicroBead
Kit and LS MACS Columns (both Miltenyi Biotec). This procedure was carried out as per the manufacturer’s guidelines.
RNA-Seq Library Preparation
The previously published LCM-Seq protocol (Picelli et al., 2014) was used for RNA-Seq library preparation from LCMmaterial in lysis
buffer. LCM caps were vortexed for 15 s and spun in a tabletop centrifuge (8000 g) for 5 min. 5 mL lysate was added to 2 mL 10mM
dNTP mix (Thermo Fisher) and 1 mL 10 mM oligodT (50-AAGCAGTGGTATCAACGCAGAGTACTTTTTTTTTTTTTTTTTTTT
TTTTTTTTTTVN-30, (IDT)). This was vortexed briefly and spun in a microcentrifuge for 30 s (700 g) then incubated at 72C for
3 min and immediately snap cooled on ice. To each reaction, 2 ml SSRTIV 53 buffer, 0.5 ml 100 mM DTT, 0.5 ml 200 U ml1 SSRTIV
(all Thermo Fisher), 2 ml 5 M betaine (Sigma-Aldrich), 0.1 ml 1 M MgCl2 (Sigma-Aldrich), 0.25 ml 40 U ml1 RNase inhibitor (Takara)
and 0.1 ml 100 mM TSO-LNA-oligo 50- AAGCAGTGGTATCAACGCAGAGTACATrGrG+G 30, Exiqon) was added. The reverse tran-
scription reaction was performed in a thermal heat cycler with the following conditions; 90min 42C, 10 cycles of (2 min 50C, 2 min
42C) and 15 s 70C. For the amplification reaction 12.5 ml 2X KAPA HiFI Hotstart Mix (KAPA Biosystems), 0.2 ml 10 mM ISPCR
primers (IDT, 50 - AAG CAG TGG TAT CAA CGC AGA GT – 30) and 2.3 ml nuclease-free H2O (Invitrogen) was added to each reaction.
This was heat cycled as follows: 3 min 98C, 18 cycles of (20 s 98C, 15 s 67C, 6 min 72C) and 5 min 72C. After bead purification
using AMPure XP beads (Beckman Coulter), the concentration of the cDNA library was measured with an Agilent 2200 TapeStation
using the High Sensitvity DNA 5000 kit (Agilent). 1 ng of cDNA from this reaction was amplified and barcoded using the Nextera XT
DNA sample preparation kit andNextera XT index kit (Illumina) following themanufacturer’s protocol. The libraries were purified again
using AMPure XP beads, analyzed on the Tapestation 2200 using High Sensitivity DNA 100 Kit and quantified using the Qubit fluo-
rometer and Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific).
For sorted populations the SMARTer Stranded Total RNA-Seq Kit v2 -Pico Input Mammalian kit (Takara) was used. Input RNA
was purified using the PicoPure RNA Isolation Kit and the protocol was followed according to the manufacturer’s guidelines.
RNA-Sequencing
All RNA-Sequencing was carried out at Edinburgh Genomics on a NovaSeq SP flowcell generating 50 base pair (bp) or 75 bp paired
end reads. LCM-Seq samples were sequenced at a read depth of approximately 29million reads per sample. Bulk-sorted population
samples were sequenced at a read depth of approximately 47million reads per sample. 10X samples were sequenced on a NovaSeq
S1 flow cell with a 26/8/91 cycle set up at a read depth of approximately 70,000 reads per cell.
LCM-Seq and Bulk Population Transcriptome analysis
The quality of the reads including Phred quality score (quality of the identification of nucleobases during sequencing) adaptor
contamination, GC content, duplicate levels was assessed using the tool FastQC (Andrews, 2010). Illumina adaptor sequences
were trimmed off reads using the tool Flexbar (Dodt et al., 2012). Readsweremapped to the human reference genome hg38 (Ensembl
version 85) using STAR (Dobin et al., 2013). SAMtools (Li et al., 2009) was used to sort and index the aligned reads. The multicov
function of BEDtools (Quinlan andHall, 2010) was used to count the read fragments per gene and generate amatrix of reads per gene.
In R, the tool DESeq2 (Love et al., 2014) was used for DGE analysis which provides log2 fold change of genes between two con-
ditions. Per embryo batch effects were corrected for. The p. value is dependent on the statistical test used within the tool which wase5 Cell Stem Cell 27, 822–839.e1–e8, November 5, 2020
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hypothesis correction with the Benjamini and Hochberg method to produce adjusted p. values (p.adj) (Benjamini and Hochberg,
1995). Genes were considered significant with a p.adj < 0.05. Principle component analyses were carried out on variance stabilizing
transformed datasets using in-built R statistical tools and visualized using ggplot2 (Wickham, 2019). Heatmaps were also carried out
on variance stabilizing transformed datasets using in-built R statistical tools and visualized using the R package pheatmap. Volcano
plots were generated using EnhancedVolcano.
Enriched gene sets were found from differentially expressed genes between two conditions using the GSEA tool from the broad
institute (Subramanian et al., 2005). In particular annotated gene sets from the following databases were used; Hallmark gene sets
(Liberzon et al., 2015), BioCarta, KEGG (Kanehisa and Goto, 2000), Reactome (Croft et al., 2011) and Gene ontology (GO) (Ashburner
et al., 2000; The Gene Ontology Consortium, 2019). Genes were input as a ranked list by Wald statistic and pathways were consid-
ered significant with a false discover rate (FDR) of < 0.25.
The String-DBwas used to find interactions between proteins from lists of genes (Szklarczyk et al., 2015, 2019). These interactions
are both direct (physical) and indirect (functional) interactions. The tool determined interactions between proteins by known interac-
tions from curated databases or that had been experimentally determined, predicted interactions from gene neighborhood, gene fu-
sions and gene co-occurrence databases, and by text mining publications, co-expression and protein homology databases. Inter-
actions were given a confidence score scaled between 0 and 1 which is a combined score for each type of evidence given and is the
estimated likelihood that a given interaction is ‘biologically meaning, specific and reproducible’. Only high confidence score (0.7) in-
teractions were used. The network matrices generated in the string-db web interface were opened in the Cytoscape software (Shan-
non et al., 2003) for production of figures and scaling of nodes by the number of interactions associated with it. EnrichmentMap was
used to consolidate pathways with a high number of overlapping contributing genes (https://www.baderlab.org/Software/
EnrichmentMap).
CellPhoneDB v2.0 (Efremova et al., 2020) was used to find ligand receptor interactions between subpopulations. Results were
computed using default settings with 1000 statistical iterations. Significant interactions were considered as having a p.value < 0.05.
Sequencing data is accessible through GEO Series accession number GEO: GSE151877.
10x Single Cell Analysis
Libraries from 10,000 CD34+ AoV cells were prepared using the Single Cell 30 Reagent Kit v2 (10x Genomics) across two lanes of the
Chromium Single Cell Chip (10x Genomics). The libraries were prepared according to the manufacturer’s protocol.
The Cell Ranger 2.1.0 (10x Genomics) analysis pipeline was used to process the 10x single cell RNA-Seq output by aligning reads
toGRCh38 human transcriptome (Ensembl). The single-cell gene expression datawas converted into a loomfile using the python tool
Loompy (https://github.com/linnarsson-lab/loompy). SCANPY (Wolf et al., 2018) was used for the follow steps 1 – 15. 1) Filtering out
cells with less than 200 genes. 2) filtering out genes that were in less than 3 cells. 3) Filtering out cells with a) high percentage mito-
chondrial genes (> 0.05) and b) a high number of genes (> 3500). 4) Normalizing reads per cell. 5) Logarithmise the data. 6) Regress out
the effects of total counts per cell and the percentage mitochondrial genes. 7) Regress out cell cycle effect. 8) Identification of highly
variable genes for principal component analysis (PCA) 9) PCA 10) Compute the neighborhood graph (n_neighbors = 8). 11) Embed the
neighborhood graph in 2 dimensions using Uniform Manifold Approximation and Projection (UMAP) (McInnes, Healy and Melville,
2018). 12) Clustering the neighborhood graph using Leiden (Traag et al., 2019). 13) Findingmarker genes per cluster using aWilcoxon
rank-sum (Mann-Whitney-U) test. 14) Mapping gene expression onto the UMAP embedding. 15) Generation of additional graphical
plots. Partition-based graph abstraction (PAGA) (Wolf et al., 2019) was used to make lineage inferences from the neighborhood
graph, using the Leiden clustering. scVelo (https://github.com/theislab/scvelo) was used to estimate the direction of RNA Velocity
(La Manno et al., 2018) across the UMAP embedding and in turn infer lineage trajectories from the PAGA-inferred cluster
relationships.
Sequencing data is accessible through GEO Series accession number GSE151877.
Imaging
Immunofluorescence
SuperFrost Plus (VWR) slides with 7mm cryosections were taken out of 20C storage and placed immediately in cold 4% PFA
(Sigma Aldrich) for 10 min. Staining steps were as follows; 3x wash in PBS, 5 min each. 10 min permeabilisation in PBS/0.5% Triton
X-100 (Sigma Aldrich). 2x 5min PBSwash. 30min PBS/10%FCS protein block. Overnight incubation with a primary antibody diluted
in PBS/2% FCS. 2x 5 min PBS wash. 2-hour incubation with secondary antibody diluted in PBS/2% FCS at room temperature. 2x
5 min PBS wash, 5 min 30nM DAPI (ThermoFisher) incubation. 1x 5 min PBS wash. Mount in Prolong Gold Antifade (ThermoFisher)
and coverslip of thickness 1.5 (VWR). Slides were left at room temperature in the dark overnight before imaging. For each staining
experiment there was a negative control with no primary antibodies and all secondary antibodies or with an isotype control and
all secondary antibodies.
RNAScope
RNAScope was carried out using the RNAscope Multiplex Fluorescent Reagent Kit v2 (bio-techne) largely following the manufac-
turer’s instructions for use with fresh frozen samples. Differences were an initial 30 min fixation of the 7mm cryosections in 4% PFA
at 4C and 30 min incubation at 37C following dehydration. Protease IV was applied for 10 min at RT. The fluorophores used were
all OpalTM Dyes (Perkin Elmer); Opal 520, Opal 570 and Opal 690. The probes used were all human RNAscope Probes; Hs-EDN1,Cell Stem Cell 27, 822–839.e1–e8, November 5, 2020 e6
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negative probes supplied in the kit.
Slides were imaged using a 5 laser Confocal TCS SP8 (Leica) and an Axio Observer Z1 InvertedMicroscope (Zeiss). All image anal-
ysis was done using ImageJ FIJI software (Schindelin et al., 2012). To quantify RNAScope EDN1 hotspots (clusters of probe signals)
the image threshold was first adjusted to filter out weak and background signals and a binary color image of probe signal versus non-
signal was generated. Process/ Binary/Watershed was used to help separate merged signals. The analysis tool was then used
to highlight any signal clusters that were 300 pixels or larger. Histology images were annotated on PowerPoint (Microsoft).
Ex vivo floating membrane aggregate cultures
E9.5 caudal parts from CD45.2/.2 BL6J mice were dissociated in 1mg/ml Collagenase-Dispase (Roche) and 0.12 mg/ml of DNase I
(Roche) for 35 min in a 37C rotating water bath. FACS buffer (PBS without Ca2+ andMg2+, 2% Foetal Calf Serum (FCS), and 50 U/ml
P/S) was added to neutralise the collagenase and cells were centrifuged for 5 min at 300 g. Supernatant was aspirated and tissues
mechanically dissociated by gentle pipetting up and down in FACS buffer. Cells were then centrifuged and washed again. Cells were
then resuspended in IMDM/20% heat inactivated FCS (Hyclone) with addition of one of the recombinant proteins; Endothelin-1 (LS-
Bioscience), Endothelin-2 (Sigma Aldrich), Renin (Sigma Aldrich) at a concentration of 10ng/ml or 100ng/ml. A no-protein control was
also included. Dissociated cells were distributed into p200 pipette tips sealed at the ends with paraffin; 1 embryo equivalent (ee) per
tube in 20ml. Tips were centrifuged at 460 g for 12min to form a pellet. For OP9 co-aggregate experiments, cells were centrifugedwith
100,000 OP9s per aggregate. The pellets were carefully deposited onto 0.8mm nitrocellulose membrane filters (Millipore) floating on
Aggregate Media (control or + 1 recombinant protein at 10ng/ml or 100ng/ml). A maximum of 5 aggregates were cultured per mem-
brane at the gas-liquid interface for 7 days at 37C, 5% CO2. After 7 days of E9.5 floating membrane aggregate culture, aggregates
were dissociated in 1mg/ml Collagenase-Dispase (Roche) at 37C for 40 min for down-stream assays.
ES Cell Differentiation
H9 ES cells were differentiated toward hematopoietic progenitors following a previously published protocol (Ng et al., 2016). All in-
cubation was carried out at 37C and 95% humidity in an atmosphere of 5% CO2. All proteins are human recombinant. Day 0: Cells
are dissociated with Accutase and plated in a U-bottom 96 well plate at 3000 cells per well in STEMdiff APEL2 (StemCell Technol-
ogies, Inc.) with BMP4 (20 ng/ml, R&D), VEGF (25 ng/ml, Peprotech), Activin A (10 ng/ml, Peprotech), FGF2 (10 ng/ml, Peprotech),
SCF (25 ng/ml, Peprotech) and ROCK inhibitor (10mM, R&D). Day 2: Addition of SB431542 (3mM, Cayman Chemicals) and Chiron
(3mM, Tocris Bioscience). Day 4: Media change; STEMdiff APEL2 (StemCell Technologies, Inc.) with BMP4 (20 ng/ml, Biotechne),
VEGF (50 ng/ml, Peprotech), FGF2 (10 ng/ml, Peprotech), SCF (50 ng/ml, Peprotech) and IGF2 (30mg/ml, Peprotech). Day 8: 96-
well flat bottom plates were coated with Biolaminin 521 (BioLamina) and EBs were transferred to new wells in new media; STEMdiff
APEL2 (StemCell Technologies, Inc.) with SCF (50 ng/ml, Peprotech), VEGF (150 ng/ml, Peprotech), FLT3L (25 ng/ml, Peprotech),
TPO (25 ng/ml, Peprotech), IL6 (25 ng/ml, Peprotech), IGF2 (20 ng/ml, Peprotech), FGF2 (10 ng/ml, Peprotech), EPO (3U/ml, Pepro-
tech) and IL3 (50 ng/ml, Peprotech). Day 12: EBs and media were both collected for downstream analysis. Endothelin-1 (100ng/ml
Sigma-Aldrich), 1nM ABT-627/atrasentan and 100nM A-192621 (kindly donated by Dr. David Webb) were added separately at day 8
of the protocol. Equal amounts of DMSO were added to each test condition and control (1:10000). Human EBs were dissociated in
1mg/ml Collagenase-Dispase (Roche) at 37C for 40 min for downstream assays.
Colony-forming assays
For mouse experiments, following culture single cells were plated on MethoCult GF M3434 (StemCell Technologies, Inc.) at a fre-
quency of 0.05 embryo equivalents per plate. Plates were cultured at 37C and 95%humidity in an atmosphere of 5%CO2. Colonies
were counted and identified on day 7 of culture.
Dissociated human EBs were plated in MethoCultTM (StemCell Technologies, Inc.) at a frequency of 5000 cells per dish. Colonies
were identified and counted after 14 days.
Long-term repopulation assay
Collagenase dissociated cells from E9.5 7 day aggregate cultures were washed and resuspended in FACS buffer with heat-inacti-
vated FCS (hyclone). CD45.1/.2 mice were irradiated prior to transplantation with a dose of 9.5 Gy, split in two doses with a 3-
hour gap in between and delivered by a sealed Cs source at a rate of 21.6 rad/min. 0.5ee were injected with a 30-gauge syringe nee-
dle into the lateral tail veins of pre-irradiated CD45.1/.2 mice with 100,000 bone marrow carrier cells isolated from the femurs of
CD45.1/.1 mice. Blood was collected from the tail vein by superficial incision of the tail vein at 8 and 18 weeks post-transplantation
to analyze blood chimerism. Rat anti-mouse CD45.1-APC (Invitrogen, 2 mg/ml, Clone: A20) and rat anti-mouse CD45.1-PE (eBio-
science, 2 mg/ml, Clone: 104) were used to stain the peripheral blood cells which were analyzed by a NovoCyte Flow Cytometer
(Acea Biosciences, Inc). At 18 weeks the mice were culled and hematopoietic tissues taken for multilineage analysis including the
spleen, bone marrow, thymus and blood. Bone marrow was flushed from the femur with FACS buffer using a syringe and 30-gauge
needle. Thymus and spleenwere choppedwith dissection scissors into fragments and pipetted up and down to flush out the hemato-
poietic cells before filtering out the remaining tissue. Red blood cells in the bloodwere lysedwith Red Blood Cell Lysis Buffer (bioRad)
for 15 min at room temperature. Cells were then stained as described below.e7 Cell Stem Cell 27, 822–839.e1–e8, November 5, 2020
ll
ResourceFlow cytometric analysis of cells
At 20 weeks post-transplantation cells from the hematopoietic organs of recipient mice were processed as described above and
analyzed formultilineage repopulation. Cells were dissociated in 1mg/ml Collagenase-Dispase (Roche) at 37C for 40min and filtered
through a 35mmnylongmesh. Cells were washed in FACS buffer (PBSwithout Ca2+ andMg2+, 2%Foetal Calf Serum (FCS), and 50U/
ml P/S) and centrifuged for 5 min at 300 g. Cells were stained for 1 hour in CD45_1-V450 (A20, BD Horizon, RRID:AB_1727490),
CD45_2-V500 (104, Biolegend, RRID:AB_10897142), b220-APC-cy7 (RA3-6B2, eBioscience, RRID:AB_394335), CD11c-PE-cy7
(N418, BioLegend, RRID:AB_493569), Ter119-FITC (Thermo Fisher, RRID:AB_465311), Gr1-PE (RB6-8C5, Thermo Fisher,
RRID:AB_466044), CD335-BV711 (29A1.4, BioLegend, RRID:AB_2563289), CD3e-APC (145-2C11, Thermo Fisher,
RRID:AB_11153519), CD4-APC (GK1.5, Thermo Fisher, RRID:AB_11152647), CD8-BV711 (53.67, BioLegend, RRID:AB_11219594).
Cells were washed in FACS buffer and 7AADwas added as live/deadmarker. Cells were then analyzed on a BD LSR Fortessa (BD). In
all cases, FMOs were used to gate negative populations. OneComp and UltraComp beads (both ThermoFisher) were stained with
single antibodies for automatic compensation by the Fortessa. All data was analyzed on FLOWJo software (BD).
QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical analyses except those incorporated into transcriptome analyses were carried out using R (https://www.r-project.org/).
Details of the statistical test used and n values where ‘‘n’’ represents the number of experiments and ‘‘N’’ represents the number of
embryos are provided in the figure legends. Measure of significance i.e., p value is also provided in the figure legends. Data were
analyzed using t test and paired t test for pairwise comparisons of means following verification of normal distribution with Sha-
piro-Wilk test. For linear correlations a Pearson correlation test was used.Cell Stem Cell 27, 822–839.e1–e8, November 5, 2020 e8
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Figure S1, related to Figure 1. 
(A) Representative images of anatomical landmarks used for identification of the region to take for LCM-Seq from CS16 
transverse sections. A’ shows the midgut loop (MG) protruding into the umbilical cord (UC), Ao= Dorsal Aorta, Mn = 
Mesonephros. A’’ shows appearance of the duodenum (Duo) and disappearance of the MG. 
(B) Table of differentially expressed genes in LCMSeq1 and LCMSeq2 analyses (+ = upregulated, - = downregulated, 
p.adj<0.05).
(C) Heatmap of ln-normalised gene expression for key endothelial and mesenchymal markers (LCM-Seq2).
(D) PCA analysis of LCM-Seq1 showing PC1 vs PC2. V=Ventral, VL=Ventro-lateral, DL=Dorsal=lateral, D=Dorsal
(E) PCA analysis of LCM-Seq2 showing PC1 vs PC2 (E’) and PC2 vs PC3 (E’’). V/DI = Ventral/Dorsal Inner, V/DM = 
Ventral/Dorsal Mid, V/DO = Ventral/Dorsal Outer, N=3 embryos. 
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Figure S2, related to Figure 1.
(A) Selected pathways enriched in both V_Inner vs V_Outer and D_Inner vs D_Outer comparisons, FDR<0.25, 
(B) Selected pathways enriched in both V_Inner vs V_Mid and D_Inner vs D_Mid comparisons, FDR<0.25. ((A-C) 
Numbers on schematics show the numbers of genes differentially upregulated in specific sub-domain, p.adj<0.05) 
(C) Top differentially enriched pathways ranked by FDR for V_Outer vs D_Outer, FDR<0.25
(D) Number of overlapping pathways (FDR<0.25) between Inner vs Outer and Mid vs Outer for the dorsal (top) and 
ventral (bottom).
(E) Top 30 genes by significance for ventral vs. dorsal contrast in each concentric layer (p.adj<0.05, NA = Ensembl ID has 
no assigned gene name).
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Figure S3, related to Figure 3. 
(A) Sorting strategy for hematoendothelial populations. The dorsal aorta (Ao) was manually bisected into ventral 
(AoV) and dorsal (AoD) and sorted based on VC and CD45 expression that gave V/D_Endo (a’), V/D_HSPC (b’),  
V/D_Hem (c’) populations. 
(B) PCA of haematoendothelial populations including D_HSPC population (B’) and after exclusion from further 
consideration (B’’). 1 and 2 indicate independent embryos.
(C) Volcano plot of differentially expressed genes between V_Endo and D_Endo populations (positive and negative 
loading respectively). 
(D) All GSEA pathways for V_Endo vs D_Endo populations. 
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Figure S4, related to Figure 3. CellPhoneDB v2.0 ligand receptor interactions for V_Inner and V_Mid
subdomains with V_Endo and V_HSPC populations. Size of spot indicates significance (-log10(pvalue)). Colour 
indicates expression levels (Log2 mean (Molecule 1 – Molecule 2). 
(A) Top interactions by p.value for V_Inner/Mid vs V_Endo. 
(B) (B) Top interactions by p.value for V_Inner/Mid vs V_HSPC. p<0.01
A
B
CDH5
Leiden PAGA
PTPRC
HSPC
Endo
HEY2 NR2F2
D
C
Figure S5, related to Figure 4.
(A) Expression mapping of ln-normalised top marker genes to CS16 AoV single cell dataset UMAP. 
(B) Expression mapping of additional ln-normalised arterial markers to CS16 AoV single cell dataset UMAP. 
(C) Subsetted central endothelial network clusters from AoV dataset with mapped ln-normalised expression of 
proliferation associated genes. The blue line outlines cluster 5. 
(D) Second CS16 single cell dataset of Ao endothelial and HSPCs (N=1). Lineage relationships predicted by PAGA 
with expression levels of key genes indicated for each cluster.
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Figure S6, related to Figure 6.
(A) EDN1, EDNRB immunostaining (confocal microscopy). Images in i and ii show enlarged area of the boxed region in (A).
(B) CDH5 and EDNRA immunostaining in the dorsal aorta (Ao) and surrounding mesenchyme. Scale bars = 50µm. Image in i
show enlarged area of the boxed region in (B).
(A) EDN1, EDNRA and EDNRB mRNA across a CS16 whole tissue section (RNAScope). NT = neural tube, NC = notochord, Ao = 
dorsal aorta, CV = cardinal vein, VA = vitelline artery. SG = spinal ganglia, scale bars = 500µm. 
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Figure S7, related to Figure 7. 
(A) Log2 fold change of the mouse AoV vs AoD at E9.5 and E10.5. Dataset from A.McGarvey et all., 2017.
(B) Edn1 mRNA expression in E10.5 dorsal aorta (Ao). Arrowhead shows Edn1 hotspot directly below IAHC. 
(C) Representative multilineage analysis of harvested recipient’s organs from reconstituted recipients shown in 
Figure 7D; 
(D) Representative donor-derived cell contribution into the recipient’s thymus of reconstituted recipients. 
(E, E’, E’’, F) Donor-derived cell composition of the bone marrow (BM), blood,spleen and thymus (each population is 
shown as a percentage of live cells).
Analysis set Dissection strategy Subdomain Shorthand Description
LCM-Seq1 D-V axis across entire Ao
calibre (Figure 1A) 
Ventral [V] Vessel wall (3-4 cells 
depth)Ventro-lateral [VL]
Dorsal-lateral [DL]
Dorsal [D]
LCM-Seq2 Concentric layers radiating 
from Ao (Figure 2A)
Ventral Inner V_Inner Endothelial/Perivascular
Dorsal Inner D_Inner Endothelial/Perivascular
Ventral Mid V_Mid Sub-aortic stroma
Dorsal Mid D_Mid Sub-aortic stroma
Ventral Outer V_Outer Outer stroma
Dorsal Outer D_Outer Outer stroma
Table S1, related to Figures 1 and 2. Nomenclature for sub-domains microdissected for LCM-Seq1 
and LCM-Seq2 analyses.
Analysis set Dorsal/Ventral Population Shorthand Description
Sorted 
haematoendothelial
populations from 
AoV and AoD
(RNAseq)
Ventral VC+CD45- V_Endo Endothelial
Ventral VC+CD45+ V_HSPC Haematopoietic 
Stem Progenitor 
Cells
Ventral VC-CD45+ V_Hem Mature 
haematopoietic
Dorsal VC+CD45- D_Endo Endothelial
Dorsal VC+CD45+ D_HSPC Haematopoietic 
Stem Progenitor 
Cells
Dorsal VC-CD45+ D_Hem Mature 
haematopoietic
Table S2, related to Figure 3. Nomenclature for the sorted HE populations dataset.
